
  • Services
    • THERAPEUTIC AREAS
      • Epilepsy & Seizure Disorders
      • Mental Illness
      • Neurodegenerative Disorders
      • Neurodevelopmental Disorders
      • Neuromuscular Disorders
      • Pain Models
      • Rare CNS Disorders
      • Injury and Trauma
    • CAPABILITIES
      • Microdyalisis
      • Biomarker Analysis
      • Pharmacokinetics & Pharmacodynamics (PK/PD)
      • Target Engagement
      • Electrophysiology
  • In Vivo AI Platforms
    • eCube™
    • NeuroCube®
    • PhenoCube®
    • SmartCube®
  • News & Insights
    • News
      • Press Releases
      • Upcoming Events
    • Insights
      • Publications
      • Posters
      • Research Updates
  • About
    • Leadership Team
    • Corporate Citizenship
    • Culture
    • Careers
  • Contact Us

Filters

Filters

Therapeutic Areas
In Vivo AI Platforms
Mental Illness
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain
Sleep & Seizure Disorders
Rare CNS Disorders
Traumatic Brain Injury
Specific Disorders
Apply Filters

Filters

AllNewsPress ReleasesUpcoming EventsPublicationsPostersResearch Updates
RESEARCH UPDATES

Spotlight on Our Tuberous Sclerosis Complex (TSC) Research and the Tsc2 KO Mouse Model

May 28, 2026
Read More
RESEARCH UPDATES

Advancing Autism Spectrum Disorders Research with PsychoGenics 

April 20, 2026
Read More
RESEARCH UPDATES

Sleep/Wake and pharmaco-EEG capabilities 

April 3, 2026
Read More
RESEARCH UPDATES

Preclinical Neurotrauma Research: Traumatic Brain Injury model

April 1, 2026
Read More
RESEARCH UPDATES

PsychoGenics Offers the Middle Cerebral Artery Occlusion (MCAO) Stroke Model

March 3, 2026
Read More
RESEARCH UPDATES

UVB Radiation Model of Inflammatory Pain 

February 3, 2026
Read More
RESEARCH UPDATES

Characterization of a Rat Model of Amyotrophic Lateral Sclerosis (ALS)

January 29, 2026
Read More
RESEARCH UPDATES

6-OHDA lesion in mice – a model of Parkinson’s Disease

January 12, 2026
Read More
RESEARCH UPDATES

Use of rodent brain slices to investigate potential anti-epileptic therapeutics

December 9, 2025
Read More
01020304Next →

Let’s Find the Right Solution Together

Our scientists are here to help you find the right model or capability for your program.

Request a Consultation

Quick Links

  • Services
  • In Vivo AI Platforms
  • News & Insights
  • About
  • Contact

Contact

Address

215 College Road
Paramus, NJ 07652

Email

info@psychogenics.com

Phone

(914) 406-8019

Fax

(914) 406-8090

© 2025 PsychoGenics Inc. All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Financial Conflict of Interest Policy
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}